SNCA and synucleinopathy: Overall, our data not only showcase the value of our pS129- and aggregate-assays in dissecting disease mechanisms in murine models, but also signify their potential in assessing the efficacy of treatments targeting α-synuclein phosphorylation or aggregation in pre-clinical murine models of synucleinopathy.